Search results: Sage Journals

Restricted accessOtherFirst published October, 2000

Pharmacist Employment and Satisfaction Trends at ELI Lilly and Company

Jennifer L. Riggins, Brandi H. Plowman

Therapeutic Innovation & Regulatory Science

Restricted accessOtherFirst published April, 1999

Globalizing Medical Information Services at ELI Lilly and Company

Jennifer L. Riggins, Kevin J. Ferguson, Sheila I. Miller [...]

Therapeutic Innovation & Regulatory Science

Restricted accessOtherFirst published January, 1998

ELI Lilly and Company Global Medical Information: Pharmacy Student Clerkships in Industry

Jennifer L. Riggins, Jeffrey L. Winn

Therapeutic Innovation & Regulatory Science

Restricted accessOtherFirst published April, 2004

Assessment of the Value of Doctor of Pharmacy Clerkship Rotations to Global Medical Information at Eli Lilly and Company

Sarah Miller, Sara Doshi, Jennifer Riggins

Therapeutic Innovation & Regulatory Science

Restricted accessResearch articleFirst published September, 2011

Eli Lilly Jr. (1885–1977): How New Science and Historic Archives Reveal a Collectors Decision-Making Process

Shirley Maloney Mueller

Collections: A Journal for Museum and Archives Professionals

Restricted accessOtherFirst published February, 1982

Moxalactam (Moxam,Eli Lilly)

Ron E. Polk

Annals of Pharmacotherapy

Free accessLetterFirst published September, 2018

In Response to Letters to the Editor From the American Diabetes Association and Eli Lilly in Regard to: Insulin Concentration in Vials Randomly Purchased in Pharmacies in the United States: Considerable Loss in the Cold Supply Chain

Alan W. Carter, Lutz Heinemann

Journal of Diabetes Science and Technology

Restricted accessOtherFirst published December, 1982

Cinoxacin (Cinobac,Eli Lilly & Co.)

David R.P. Guay

Annals of Pharmacotherapy

Restricted accessResearch articleFirst published January, 1980

Cefaclor (Ceclor® - Eli Lilly and Company)

H. David Bergman, Eric A. Jackson, Alex A. Cardoni

Annals of Pharmacotherapy

Restricted accessBrief reportFirst published November, 2022

Eli Lilly to Acquire Akouos for up to $610M

Alex Philippidis

Human Gene Therapy

Restricted accessOtherFirst published October, 2000

Pharmacist Employment and Satisfaction Trends at ELI Lilly and Company

Jennifer L. Riggins, Brandi H. Plowman

Therapeutic Innovation & Regulatory Science

Restricted accessOtherFirst published April, 1999

Globalizing Medical Information Services at ELI Lilly and Company

Jennifer L. Riggins, Kevin J. Ferguson, Sheila I. Miller [...]

Therapeutic Innovation & Regulatory Science

Restricted accessOtherFirst published January, 1998

ELI Lilly and Company Global Medical Information: Pharmacy Student Clerkships in Industry

Jennifer L. Riggins, Jeffrey L. Winn

Therapeutic Innovation & Regulatory Science

Restricted accessOtherFirst published April, 2004

Assessment of the Value of Doctor of Pharmacy Clerkship Rotations to Global Medical Information at Eli Lilly and Company

Sarah Miller, Sara Doshi, Jennifer Riggins

Therapeutic Innovation & Regulatory Science

Restricted accessResearch articleFirst published September, 2011

Eli Lilly Jr. (1885–1977): How New Science and Historic Archives Reveal a Collectors Decision-Making Process

Shirley Maloney Mueller

Collections: A Journal for Museum and Archives Professionals

Restricted accessOtherFirst published February, 1982

Moxalactam (Moxam,Eli Lilly)

Ron E. Polk

Annals of Pharmacotherapy

Free accessLetterFirst published September, 2018

In Response to Letters to the Editor From the American Diabetes Association and Eli Lilly in Regard to: Insulin Concentration in Vials Randomly Purchased in Pharmacies in the United States: Considerable Loss in the Cold Supply Chain

Alan W. Carter, Lutz Heinemann

Journal of Diabetes Science and Technology

Restricted accessOtherFirst published December, 1982

Cinoxacin (Cinobac,Eli Lilly & Co.)

David R.P. Guay

Annals of Pharmacotherapy

Restricted accessResearch articleFirst published January, 1980

Cefaclor (Ceclor® - Eli Lilly and Company)

H. David Bergman, Eric A. Jackson, Alex A. Cardoni

Annals of Pharmacotherapy

Restricted accessBrief reportFirst published November, 2022

Eli Lilly to Acquire Akouos for up to $610M

Alex Philippidis

Human Gene Therapy